Overall survival by initial treatment modality (transarterial chemoembolization vs. sorafenib) according to pre-defined subgroups.
收藏NIAID Data Ecosystem2026-03-11 收录
数据链接：
官方服务：
资源简介：
Overall survival by initial treatment modality (transarterial chemoembolization vs. sorafenib) according to pre-defined subgroups.
创建时间：
2019-03-07
